Artenie A, Artenie R, Covic M, Haulică I
Spital Clinic nr. 2 Iaşi, Clinica a IV-a Medicală, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2001 Jul-Sep;105(3):462-8.
Diabetic nephropathy (DN) is the most important cause of increased morbidity and mortality in patients with diabetes mellitus. Moreover DN is associated with a high risk for cardiovascular complications and progression of renal failure. It is known that there is a cumulative risk of development of DN represented by genetic factors, glycaemic factors, hypertension, alterations in the lipid metabolism, smoking. Functionally, it is represented by increased glomerular filtration rate (silent phase) and renal hypertrophy, increased the urinary albumin excretion rate, increased blood pressure and decline in glomerular filtration rate (end phase). Biochemical DN induced the alterations in lipid metabolism (increased the serum concentrations of triglicerides, VLDL, LDL), alterations in glycaemic metabolism (blood glucose, glycated hemoglobin, glycated albumin). The correlations between clinical and biochemical aspects are developed in this reference.
糖尿病肾病(DN)是糖尿病患者发病率和死亡率增加的最重要原因。此外,DN与心血管并发症和肾衰竭进展的高风险相关。已知DN的发生存在由遗传因素、血糖因素、高血压、脂质代谢改变、吸烟所代表的累积风险。在功能上,它表现为肾小球滤过率增加(无症状期)和肾肥大、尿白蛋白排泄率增加、血压升高以及肾小球滤过率下降(终末期)。生化方面,DN会引起脂质代谢改变(甘油三酯、极低密度脂蛋白、低密度脂蛋白的血清浓度升高)、糖代谢改变(血糖、糖化血红蛋白、糖化白蛋白)。本参考文献阐述了临床和生化方面的相关性。